Background
The genus
Aeromonas is a common, gram-negative, facultative anaerobe, coccobacillary-to-bacillary bacteria that belongs to
Aeromonadaceae [
1]
.The genus
Aeromonas is comprised of mesophiles and psychrophiles which can cause a number of diseases to warm and cold-blooded animals [
2]. Recently, mesophilic
Aeromonas have received increased attention as an emergent agent of foodborne illness [
3]. In humans,
Aeromonas can cause extra-intestinal diseases, especially in immunocompromised individuals, including septicemia, wound infections, urinary tract infections, hepatobiliary tract infections and necrotizing fasciitis [
4].
Aeromonas have a complex taxonomy and the genus is comprised of over 30 species, however their identification has been limited by use of conventional biochemical identification methods such as matrix-assisted laser desorption/ionization time of flight masss spectrometry (MALDI-TOF MS), and 16S ribosomal ribonucleic acid (rRNA) sequencing [
5‐
8]. To this end, the use of 5 or more housekeeping genes has been demonstrated as an effective approach for multilocus phylogenetic analysis (MLPA) and species identification of
Aeromonas spp. [
5,
9]. In addition, MLPA has been recommended for the verification of taxonomic affiliation by genome sequencing before being submitted to the NCBI database [
10]. Current literature indicates that
A. hydrophila,
A. veronii bv sobria, and
A. caviae are responsible for the majority of human infections and clinical isolations [
11]. However, caution must be exercised as
A. dhakensis can be misidentified as
A. hydrophila by use of some phenotypic methods [
12] and MLPA is suggeted for molecular subtyping [
13,
14].
A. dhakensis was initially described as a
A. hydrophila subspecies in 2002, and
A. aquariorum described later, and was recommended to be reclassified as a separate species in 2012 [
15].
The pathogenesis of
Aeromonas spp. involves a series of virulence factors [
16]. Haemolytic toxins include: aerolysin-related cytotoxic enterotoxin (Act) [
17], heat-labile cytotonic enterotoxin (Alt), heat-stable cytotonic toxins (Ast) [
18], hemolysin (HlyA) and aerolysin (AerA) [
19]. In addition, the type III secretion system (TTSS) [
20], polar flagellum (fla), lateral flagella (laf) [
21,
22], elastase (Ela) [
23] and lipase (Lip) [
24] contribute to the pathogenicity of
Aeromonas.
Most cases of diarrheal due to
Aeromonads are self-limiting and treatment with oral or intravenous fluids is effective. However, patients with serious diarrhea or extra-intestinal infection should receive an antimicrobial treatment [
2]. Previously,
Aeromonas has been observed as resistant to ampicillin, while 3rd generation cephalosporin, fluoroquinolone and aminoglycosides demonstrated excellent antimicrobial activity to
Aeromonas species isolated from clinical sources [
14,
25‐
27]. However, extensive use of antibiotics in aquaculture and human treatment has led to increasing resistance in bacterium to antimicrobial drugs. Therefore it is prudent to monitor the development of antimicrobial resistance in species of
Aeromonas to common clinical treatment options.
In the presented study, we investigated characteristics of strains of Aeromonas isolated from intestinal infections and extra-intestinal infection. Furthermore we evaluated virulence associated genes and antimicrobial resistance of species of Aeromonas.
Materials and methods
Isolates of Aeromonas
Overall, 1286 stool samples were collected from adults over 14 years old presenting with acute diarrhea at a general hospital in Beijng, China, between June and July 2015, 2017. Epidemiology related medical records were completed to assess clinical history and physical fitness of patients (Additional file
1). Samples of Stool were enriched in alkaline peptone water broth (Beijing landbrige, China) for 8 h at 37 °C, and a loop of the resulting mixture was subcultured on a blood agar plate (Oxoid, UK) supplemented with 20% ampicillin (Sigma, USA) for 16–24 h at 37 °C [
28]. An oxidase test (BioMerieuX, France) was performed to select the colonies which were different from Enterobacteriaceae. Microorganisms were identified by use of an automatic bacteriologic analyzer (VITEK2 Compact, BioMerieuX, France).
Salmonella spp,
Shigella spp and
Vibrio spp were also detected on a routine basis. simultaneously.
Extra-intestinal infections due to Aeromonas were monitored and the strains were isolated between 2015 and 2017. Clinical samples of blood or bile were cultured in a BACTEC FX400 (BD Diagnostic Instrument Systems, USA). Samples positive for Aeromonas were simultaneously subcultured on a blood agar plate and a Maconkey agar plate (BioMerieuX, France). Identification of the isolated microorganisms was completed by use of an automatic bacteriologic analyzer (VITEK2 Compact, BioMerieuX, France). Concurrently, medical records of the patients with extra-intestinal infections due to species of Aeromonas were reviewed and age, gender, underlying conditions, microbiological findings and outcome were assembled.
Strains were stored in a Luria broth: glycerol mixture (80:20) at − 80 °C until identification was performed.
Molecular identification and subtyping of Aeromonas isolates
Molecular identification and subtyping of
Aeromonas isolates was completed by use of 16S rRNA sequencing and MLPA. Total chromosomal DNA from
Aeromonas was prepared by use of the DNA purification kit (Tiangen Biotech, China) as specified by the manufacturer. PCR amplification was performed by use of 2 × Taq PCR MasterMix (Tiangen Biotech, China). Primers synthesis and sequencing of PCR products were conducted (Shanghai Sangon Biotech, China). Due to the limitations of molecular identification by 16S rRNA sequencing, phylogenetic analysis of the seven selected housekeeping genes
gyrB,
rpoD,
recA,
dnaJ,
gyrA,
dnaX and
atpD was completed to identify strains of
Aeromonas. Primers [
5] used for PCR amplification are provided in Additional file
2. Concatenated 7-gene phylogenetic trees were constructed and compared with representative species by use of MLPA as previously described [
5]. Unrooted neighbour-joining phylogenetic trees were prepared by use of MEGA 5.0 software with Bootstrap values calculated by use of 1000 replicates.
Detection of virulence-associated genes
The presence of 10 genes encoding virulence factors was determined by use of PCR. Primers are listed in Additional file
2, including
alt [
29],
ast [
30],
hlyA,
aerA, act, ascF-G of TTSS,
laf [
14],
lip,
fla, and
ela [
31]. PCR amplification reactions were performed at a final volume of 40 μl, containing 20 μl of Taq PCR MasterMix (2×), 1 μl 10 μM primer, 1 μl DNA template (~ 30-40 ng), and 17 μl ddH
2O. Cycling conditions consisted of an initial single cycle at 95 °C for 5 min, followed by 30 cycles of denaturation at 95 °C for 30 s, annealing was completed at 55 °C–60 °C for 30 s, elongation was completed at 72 °C for 1 min and followed by a final cycle at 72 °C for 7 min. The PCR products were sequenced for further confirmation.
Antibiotic susceptibility test
Antibiotic susceptibility tests were performed by use of the microbroth dilution method according to guidelines of the current Clinical and Laboratory Standards Institute (CLSI). Minimum inhibitory concentrations (MIC) of strains of Aeromonas strains to 15 antibiotics were determined and included; gentamycin (GEN), imipenem (IPM), ampicillin (AMP), cefoxitin (FOX), ceftriaxone (CRO), amoxicillin-clavulanate (AMC), nalidixic acid (NAL), ciprofloxacin (CIP), chloramphenicol (CHL), tetracycline (TCY), doxycycline (DOX), azithromycin (AZM), cefepime (FEP), sulfonamides (Sas) and trimethoprim-sulfamethoxazole (SXT). E. coli ATCC 25922 was used as the quality-control strain for susceptibility testing.
Definitions
Multiple drug resistance (MDR) was was defined as acquired non-susceptibility to at least one agent in three or more antimicrobial categories, according the criteria for defining MDR, XDR and PDR in
Enterobacteriaceae [
32].
Intestinal infections related to a strain of Aeromonas were diagnosed as patients presenting with acute diarrhea and a sample culture positive for a strain of Aeromonas. Extra-intestinal infections related to a strain of Aeromonas were diagnosed as patients presenting with inflammation in a region not identified as intestinal and a sample culture positive for a strain of Aeromonas.
Statistical methods
Data were analyzed by use of the x2 test and Fisher’s exact test (SPSS 15.0), When P < 0.05 results were considered statistically significant.
Discussion
In the presented study, 115 isolates of
Aeromonas were collected from a general hospital in Beijing between 2015 and 2017. Overall, the abundance and prevalence of strains of
Aeromonas were different between intestinal and extra-intestinal infections. In our study, 1% of samples isolated from samples of stool of patients with intestinal infection were positive for
A. hydrophila, while in 29.4% of extra-intestinal infections. Thus, results of this study indicated that the
A. hydrophila was not the primary pathogen contributing to acute gastroenteritis, however it was more prevalent in extra-intestinal infections when compared to samples from patients with intestinal infections. Interestingly, 5 strains of
A. hydrophila strains from extra-intestinal infections were present in patients presented with malignant tumor. These results might indicate a preference of strains of
A. hydrophila and other
Aeromonas spp. to colonize differently
. A. veronii was more common in samples of patients presenting with acute gastroenteritis (35.7%) but was rare in patients with extra-intestinal infections (5.9%), which was similar to previous results [
14,
33].
In addition, results of our study demonstrate a potential relationship between
Aeromonas and clinical cirrhosis or malignancy as previously reported [
34,
35] and liver-transplant related cholecystitis. These results might be related to bacterial translocation, use of antacids [
35] or immunosuppressive agents following liver transplantation.
Prevalence of antimicrobial-resistance was greater in extra-intestinal isolates when compared to the previous study. In our study, rates of resistance to ceftriaxone, ciprofloxacin, gentamicin and imipenem was 70.6, 35.3, 23.5 and 5.9%, while a study completed in Taiwan was 7.7, 6, 3.3 and 1.1%, respectively [
36] . Additionally, a study completed in Korea the rates of resistance were 15.5, 10.1, 7.1 and 9.8%, respectively [
11]. When compared with the rates of intestinal isolates, the rate of MDR in extra-intestinal isolates was greater. These findings indicate selective pressures in hospitals on strains of infectious bacteria due to the extensive use of antimicrobial agents and warrants more attention in the future.
In our study, two bacteremia-related
Aeromonas species were identified;
A. media and
A. dhakensis. These results were different from previous results where
A. caviae was identified as bacteremia-related
Aeromonas species in Japan,
A. hydrophila and
A. veronii biovar sobria in Taiwan, and
A. hydrophila and
A. caviae in Korea and Taiwan [
11,
36].
A study completed in Southern India reported a resistance rate to ceftriaxone resistant of 31% (9/29) for isolates of
Aeromonas from samples of stool [
37]. In our study resistance rates for ceftriaxone, ciprofloxacin and gentamicin and imipenem were 5.1, 1.0, 2.0 and 2.0% in
Aeromonas isolates of patients presenting with diarrhea and were similar to rates in Shanghai (5.7, 3.6, 0.5, and 2.6%, respectively) [
14]. These results along with results of the study competed in Shanghai indicate that 3rd generation cephalosporins, fluoroquinolones and aminoglycosides are a treatment option for severe diarrhea but not for extra-intestinal infections originating in Eastern China.
It is important to note that only 3 strains exhibited resistance to imipenem, all of which belonged to the genus
A. dhakensis. The genus
A. dhakensis should be the focus of future research as they harbored high numbers of virulence genes, high rates of drug resistance and a high degree of infection in intestinal and extra-intestinal samples. In addition,
A. hydrophila presented with a high number of virulence genes and high rates of drug resistance.
A. hydrophila have previously been isolated from wounds in two cases as reported by Christopher J. Grim et al. [
38], and were classified as having MDR and multiple virulence genes.
In the presented study,
Klebsiella pneumoniae was the most common combined pathogen. These results demonstrate that cholecystitis post Liver transplant predisposed patients to polymicrobial
Aeromonas infections, while malignant cancers, such as rectal cancer, might predispose patients to monomicrobial
Aeromonas infection. A previous study in Taiwan found that
E. coli was the most common pathogen (42%) in polymicrobial infections, then
Klebsiella spp. (24%) [
35]. Conversely, cirrhosis predisposed patients to monomicrobial
Aeromonas bacteremia while malignant cancer predisposed patients to polymicrobial
Aeromonas bacteremia [
35]. This difference indicates a high degree of heterogeneity in the distribution of intestinal bacteria, and region specific presence of
Aeromonas infections.
The pathogenic mechanism of
Aeromonas was multifactorial and complex, and likely involves a series of virulence genes involved in this process. Despite
Aeromonas harboring different numbers and types of virulence genes, there was no significant correlation found between infection and virulent genes of
Aeromonas in intestinal infections and extra-intestinal infections. For example, intestinal infections,
alt have been reported as associated with loose stool,
alt plus
ast with watery stools, and
act with bloody diarrhea [
39]. In the presented study, 3 watery stool samples were associated with
ast, however 25 samples of watery stool were not. In addition, a relationship between infection and presence of virulent genes was not observed and might be related to the limited number of strains isolated in extra-intestinal infections. Similarly, a study completed by Wu et al. found no association between the presence of the genes
aerA, hlyA, alt, ast, ascFG in isolates of Aeromonas and development of extra-intestinal infections or bacterium [
34].
In conclusion, Aeromonas spp. should be considered as a causative infectious agent in immunocompromised patients especially those presenting with malignancy, liver cirrhosis and following a liver transplant. In addition, A. hydrophila was more prevalent in extra-intestinal infections when compared to intestinal infections, especially for patients presenting with a malignancy. Extra-intestinal Aeromonas isolates possessed higher rates of drug resistance. However, 3rd generation cephalosporins, fluoroquinolones and aminoglycosides remain as effective treatments for patients presenting with severe diarrhea but not for extra-intestinal infections. In addition, increasing prevalence of drug resistance and MDR in extra-intestinal isolates of Aeromonas requires attention and further monitoring.